[#DIV28SUPER] NIDA Notice of Pre-Application Information Webinar for PAR-21-183, "Developing Digital Therapeutics for Substance Use Disorder"

The National Institute on Drug Abuse will host an informational webinar to provide information and respond to questions from prospective applicants who may be interested in submitting grant applications in response to the Funding Opportunity Announcement (FOA) PAR-21-183 - Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional).

 

The webinar will take place on Monday, June 7th, 2021 at 2:00 PM United States Eastern Standard Time (EST).

 

Details on how to join this webinar can be found here: Pre-application webinar for PAR-21-183

 

Details on the FOA "Developing Digital Therapeutics for Substance Use Disorders" can be found here: PAR-21-183

 

For more information, please contact Dr. Will M. Aklin, aklinwm@nida.nih.gov, or Dr. Kevin Walton, kevin.walton@nih.gov.

 

Best regards,

Will

 

--

Will M. Aklin, Ph.D.

Director, Behavioral Therapy Development Program (BTDP)

Clinical Research Grants Branch

Division of Therapeutics and Medical Consequences (DTMC)

National Institute on Drug Abuse

National Institutes of Health

3WFN, Room 08A18, MSC 6016

301 North Stonestreet Avenue

Bethesda, MD 20892

301-827-5909

aklinwm@mail.nih.gov